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Abstract
Background: Maternal immune activation (MIA) is a risk factor for neurodevelopmental disorders such as autism
and schizophrenia, as well as seizure development. The amygdala is a brain region involved in the regulation of
emotions, and amygdalar maldevelopment due to infection-induced MIA may lead to amygdala-related disorders.
MIA priming of glial cells during development has been linked to abnormalities seen in later life; however, little is
known about its effects on amygdalar biochemical and cytoarchitecture integrity.
Methods: Time-mated C57BL6J mice were administered a single intraperitoneal injection of 50 μg/kg lipopolysaccharide
(LPS) on embryonic day 12 (E12), and the effects of MIA were examined at prenatal, neonatal, and postnatal
developmental stages using immunohistochemistry, real-time quantitative PCR, and stereological quantification of
cytoarchitecture changes.
Results: Fetal brain expression of pro-inflammatory cytokines (IL-1β, TNFα, and IL-6) was significantly upregulated
at 4 h postinjection (E12) and remained elevated until the day of birth (P0). In offspring from LPS-treated dams,
amygdalar expression of pro-inflammatory cytokines was also increased on day 7 (P7) and expression was sustained
on day 40 (P40). Toll-like receptor (TLR-2, TLR-4) expression was also upregulated in fetal brains and in the postnatal
amygdala in LPS-injected animals. Morphological examination of cells expressing ionized calcium-binding adaptor
molecule 1 (Iba-1) and glial fibrillary acidic protein (GFAP) suggested long-term microglial activation and astrogliosis in
postnatal amygdalar regions.
Conclusions: Our results showed that LPS-induced MIA at E12 induces a pro-inflammatory cytokine profile in the
developing fetal brain that continues up to early adulthood in the amygdala. Inflammation elicited by MIA may
activate cells in the fetal brain and lead to alterations in glial (microglia and astrocyte) cells observed in the postnatal
amygdala. Moreover, increased pro-inflammatory cytokines and their effects on glial subpopulations may in turn
have deleterious consequences for neuronal viability. These MIA-induced changes may predispose offspring to
amygdala-related disorders such as heightened anxiety and depression and also neurodevelopmental disorders, such
as autism spectrum disorders.
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Background
Compelling evidence suggests that early life challenge, as a
result of maternal immune activation (MIA), can have long-
lasting, negative effects on neurochemistry, brain excitabil-
ity, and behavior [4, 5, 22, 43]. Epidemiological studies show
that prenatal/neonatal immune activation such as infection,
malnutrition, stress, and obstetric complications can in-
crease the susceptibility of individuals to schizophrenia, aut-
ism spectrum disorders (ASD), and epilepsy [7, 22, 27]. The
literature reveals that infection-induced MIA has profound
effects on developing neural circuits with studies suggesting
that certain gestational windows are more vulnerable than
others (e.g., early versus late pregnancy) to developmentally
initiated functional deficits following MIA [22, 29]. Animal
models have been developed to study the link between be-
havioral discrepancies and cellular, molecular, and morpho-
logical alterations in the offspring’s brain after prenatal
exposure to an immune modulating agents such as polyino-
sinic:polycytidylic acid (poly I:C) and lipopolysaccharide
(LPS) which mimic viral or bacterial infections, respectively
[1, 6, 17, 22]. In rodents, early-life exposure to LPS induces
the production of pro-inflammatory cytokines such as
interleukin (IL)-1β, IL-6, and tumor necrosis alpha (TNFα)
both in the periphery and the brain [35]. Additionally, MIA
induced with LPS challenge has produced abnormalities
such as decreased expression of Reelin (structural marker),
increased immunoreactivity for glial fibrillary acidic protein
(GFAP), activation of microglial cells, long-term changes in
GABAergic function, and decreases in neocortical and hip-
pocampal thickness [12, 15, 26, 32]. Exposure of pregnant
dams to other inflammatory agents during gestation also
results in deficits that include other hippocampal abnor-
malities, such as neuronal loss, astrogliosis, and changes in
neurotransmitter receptor expression [1, 34, 36]. Several
studies have focused on the developing hippocampus,
cortex, and mid-brain, but surprisingly, research on MIA-
induced amygdalar changes is limited [22]. The amygdala, a
limbic structure, is the center for the control of emotions,
and disturbances to this component of the limbic system
can result in behavioral deficits as seen with anxiety, fear,
learning and memory impairments, and also neurodevelop-
mental disorders such as ASD [20]. Moreover, human MRI
studies and in vivo animal studies support the link
between developmental disorders and amygdalar in-
volvement [19, 20, 38]. Therefore, the first aim of this
study was to investigate the effects of LPS-induced MIA
on murine amygdalar development with regard to the
cellular, molecular, and cytoarchitectural changes that may
occur over key developmental stages.
Methods
Animals
All procedures were carried out in accordance with
Republic of Ireland Department of Health and Children
Licenses. The procedures used in this study had the
approval of the Institutional Animal Care and Use
Committee and were carried out in accordance with the
European Council Directive of November 24, 1986 (86/
609/EEC). Pregnant C57BL/6J mice were used and con-
firmation of a vaginal plug was designated as embryonic
day zero (E0) (n = 4/group/time point). All pregnant
dams were treated at embryonic day 12 (E12) and were
randomly assigned to receive a single intraperitoneal
(i.p.) injection of either lipopolysaccharide from Escheri-
chia coli 026:B6 (LPS; 50 μg/kg; Sigma-Aldrich, Ireland)
or 100 μl 0.9% saline vehicle. Male and female offspring
were used for all experiments. The first day of birth was
termed P0. Developmental stages were divided into pre-
natal/neonatal (E12, E16, E18, and P0) and postnatal
(P7, P14, and P40) stages. All animals were housed on
12-h light/dark cycle (light on 0800 h) at constant
temperature of 21 ± 2 °C with food and water available
ad libitum.
Tissue preparation
Pregnant dams were anesthetized using isoflurane and
decapitated. A midline incision was made into the peri-
toneal cavity to expose embryos. Control and LPS off-
spring were sacrificed at seven ages: E12, E16, E18, and P0
(prenatal/neonatal) and P7, P14, and P40 (postnatal).
One- and 7-day-old mice were anesthetized by
hypothermia, while 14- to 40-day-old mice were anesthe-
tized using isoflurane and promptly decapitated. For mo-
lecular analysis, whole brains were removed (E12: 4-h
post-, E16: 4-day post-, and E18: 6-day postinjection, and
P0: neonatal (first day of birth)) or the amygdalar regions
dissected out (P7, P14, and P40), snap-frozen with li-
quid nitrogen, and stored at − 80 °C until qPCR was
carried out. For histological analysis, embryos were dis-
sected out and immersion-fixed in 4% paraformaldehyde
(PFA) overnight followed by 30% sucrose (E18 and P0
brains were removed from the skull). Offspring at P7, P14,
and P40 were deeply anesthetized and transcardially per-
fused with 0.05 M PBS followed by 4% PFA in 0.05 M
PBS. Brains were removed from the skull and postfixed in
4% PFA overnight followed by 30% sucrose. The litters
were split and assigned for molecular or histological
assessment.
Immunohistochemistry (IHC)
Coronal 40-μm-thick sections (one-in-six series) were
sectioned using a cryostat (Leica Microsystem GmbH,
Wetzlar, Germany). The first and second series of sec-
tions were used for immunohistochemistry (IHC). The
third series was Nissl-stained with 0.1% Cresyl Violet
(CV) to identify structural alterations and neuronal
damage. Processed sections were dehydrated, cleared in
histolene, and coverslipped using DPX (Sigma-Aldrich,
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Wicklow, Ireland). The first and second series of sec-
tions were processed for immunohistochemistry using
specific antisera against glial fibrillary acidic protein
(GFAP) (1:2000, ab53554 goat polyclonal GFAP antibody
Abcam, Cambridge, UK) and ionized calcium-binding
adaptor molecule 1 (Iba-1) (1:1000, ab5076 goat poly-
clonal Iba-1 antibody Abcam, Cambridge, UK), respect-
ively. Bound antibody was detected using a biotinylated
secondary antibody and the avidin-biotin-peroxidase com-
plex (ABC) method (Vector laboratories, Peterborough,
UK). Immunohistochemical staining was visualized using
3′,3′-diaminobenzidine (Sigma Aldrich, Wicklow, Ireland)
as a chromogen.
Microglia (Iba-1) cell counting and astroglial (GFAP)
scoring
The amygdala region was delineated in postnatal animals
using the mouse atlas. Iba-1 staining was used to exam-
ine the morphology of microglial cells. For each animal
case, four sections were quantified and the number of
total number of Iba-1-positive cells was counted with
aid of ImageJ software. Iba-1-positive cells were divided
into activated and resting and calculated as a percentage
of total microglia present in that region. Iba-1-positive
cells were counted in the postnatal amygdala and subdi-
vided into ramified versus amoeboid-like morphology
[40]. The quantification is displayed as total (%) of cells
counted in the region. GFAP staining was analyzed as an
indication of astrogliosis and inflammation in the amyg-
dala in MIA offspring in comparison to saline-treated
controls. GFAP-positive immunostaining per region was
scored (n = 4 per treatment/group) with slight modifications
according to O’Loughlin et al. [30] by performing back-
ground correction with the aid of ImageJ software. Density
of GFAP-positive cells and variation in the staining intensity
(somata and cellular processes) were included into scoring
in a blinded manner as − = none (0% stained), + = very few
cells (< 10% of area stained), ++ = few cells (10–25% of
area stained), +++ = moderate number of cells (25–50% of
area stained), and ++++ = numerous cells (> 50% stained).
Quantification of postnatal amygdalar volumes and
neurons
Volumes of postnatal amygdalar regions were assessed
according to the Cavalieri principle [16]. Amygdalar
nuclei were delineated in Nissl-stained sections using a
mouse atlas [13]. Consecutive sections (section sampling
fraction (ssf ) 1:6, sections 120 μm apart from each
other) were sampled in saline- and LPS-injected off-
spring at three ages: P7, P14, and P40. Volumes were
calculated using the formula: V = ∑Pi · a(p) ·d, where Pi
is the sum of hit point counts in all sections, a(p) is the
area associated with each point, and d is the section spa-
cing. In the amygdala, the volumes of the lateral (LA),
basolateral (BLA), and central (Ce) nuclei were mea-
sured in consecutive sections, commencing at Bregma −
0.70 to − 2.30 mm according to the mouse atlas [13].
Total numbers of neurons were estimated in Nissl-
stained amygdalar nuclei using the optical dissector
method [16]. Neurons were distinguished from astrocytes
and oligodendrocytes based on cell and nuclear size,
amount of nuclear heterochromatin, and organization of
nucleolus [9]. Consecutive sections (1 in 6 series; 120 μm
apart) throughout the rostro-caudal extent of the amygdala
were used in saline- and LPS-injected offspring at three
ages: P7, P14, and P40, (Bregma − 0.70 to − 2.30 mm) [13].
An Olympus BX 40 microscope (×100 objective) was used
to count the neurons. An unbiased counting frame with in-
clusion and exclusion lines was superimposed, and neurons
that lay between the boundaries were counted. The focal
plane was moved down the z-axis using a digimatic mi-
crometer that was attached to the stage of the microscope
to measure the z-axis depth. The following equation was
used: E(N) = Nv X Vref, as previously described in detail
elsewhere [41].
RNA extraction, cDNA synthesis, and qPCR assay
Total RNA was extracted from brain/amygdala samples
using Qiagen RNeasy Plus Lipid mini kit as per manufac-
turer’s guidelines (Qiagen, Crawley, UK). Next, cDNA was
generated from total RNA using a High Capacity Reverse
Transcriptase Kit (Applied Biosystems, Warrington, UK).
All real-time quantitative PCR were performed using
StepOne™ Real-Time PCR system (Applied Biosystems)
with TaqMan® Gene expression Master Mix (Applied
Biosystems) and the specific TaqMan® Gene Expression
Assay for the following targets: IL-β (Mm00434228_m1),
TNFα (Mm00443258_m1), IL-6 (Mm00446190_m1), TLR-2
(Mm00442346_m1), TLR-4 (Mm00445273_m1), COX-2
(Mm00478374_m1), iNOS (Mm00440502_m1), CD36
(Mm00432403_m1), and CCL2 (Mm00441242_m1)
(Applied Biosystems). All samples were run in tripli-
cate. The mRNA expression levels between samples were
normalized using β-Actin (Mm02619580_g1) endogenous
control (VIC dye labeled, Applied Biosystems™). The
quantification of mRNA expression in the LPS treatment
groups relative to the saline control (fold change) was
done using the 2−ΔΔCT method [39].
Statistics
Statistical analyses were carried out using GraphPad
Prism software version 7. Data were represented as
mean values ± the standard error of the mean (SEM).
For histology quantification, Student’s t test was used to
compare parametric data of two treatment groups. Gene
expression profiles were analyzed with one-way ANOVA
followed by Tukey’s multiple-comparison post hoc test.
Differences were considered to be significant only for
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***p < 0.001, **p < 0.01, and *p < 0.05. There were
four pregnant mice (n = 4) in each treatment group/
time point.
Results
Bacterial induced MIA increases the production of
inflammatory cytokines in the prenatal brain and
postnatal amygdala
We first investigated the effect MIA on inflammatory
cytokine expression at different stages of development.
The amygdala nuclei originate from different domains of
the embryonic brain maturating at different develop-
mental stages [25], and the size of the amygdala was too
small to be dissected out reliably in the pre- and neo-
natal brain. Therefore, we divided the developmental
ages into two groups (prenatal/neonatal and postnatal).
Whole brain lysates were analyzed at E12 (4-h postinjec-
tion), E16, E18, and P0 in prenatal/neonatal stages, and
the amygdala was dissected under the microscope at
postnatal stages P7, P14, and P40 (Fig. 1a). One-way
ANOVA for the main factor age showed a significant ef-
fect for IL-1β (F(4, 15) = 5.97, p = 0.010, TNFα (F(4,
15) = 4.93, p = 0.0186), IL-6 (F(4, 15) = 3.178, p = 0.05),
and IL-10 (F(4, 15) = 7.713, p = 0.0042) in the prenatal/
neonatal development stages. Likewise, a significant age
effect was observed postnatally for IL-1β (F(3, 12) = 8.42,
p = 0.0028), but no significant differences were recorded
for IL-6 (F(3, 12) = 2.27, p = 0.1325), TNFα (F(3,
12) = 2.013 p = 0.1660), or IL-10 (F(3, 12) = 0.982,
p = 0.4337). Data showed there was a rapid response
to MIA-LPS with mRNA induction of several pro-
inflammatory genes including IL-1β and TNFα. Specifically,
MIA significantly increased mRNA expression of IL-1β at
E12 by sixfold as indicated by post hoc analyses (Fig. 1b;
*p = 0.011). Expression levels were also significantly higher
at E12 in comparison to P0 (Fig. 1b; *p = 0.011). In the
postnatal amygdala, IL-1β was increased approximately six-
fold at P7 with levels decreasing but remaining significantly
elevated at P40 (Fig. 1c; **p = 0.0032). IL-1β was also higher
at P7 in comparisons to P14 (**p = 0.0095) and P40
(*p = 0.0156). IL-6, an important neuro-immune regulator,
was increased about threefold after MIA on the first post-
natal day P0 (Fig. 1b; *p = 0.05). In the postnatal amygdala,
IL-6 was elevated across all ages (P7 to P40), which how-
ever did not reach significance (Fig. 1c). TNFα, another
pro-inflammatory cytokine, was elevated across prenatal
ages with significant increases at E16 (*p = 0.019) and at
E18 (*p = 0.044) in comparison to saline-treated controls,
but was not significantly increased in the postnatal amyg-
dala (Fig. 1b, c). IL-10 is a known anti-inflammatory cyto-
kine, and its expression was significantly increased at E16
in the prenatal brain in comparison to saline-treated con-
trols (Fig. 1b; **p = 0.003). IL-10 mRNA levels were higher
at E16 in comparison to E12 (*p = 0.0103), E18
(*p = 0.014), and P0 (**p = 0.0057) but remained unaffected
at postnatal ages as indicated by post hoc analyses. Taken
together, the data shows that offspring from MIA-induced
dams had an elevated inflammatory response in the CNS
from 4 h postinjection to early adolescence at P40.
Acute maternal exposure to LPS induces increased
expression of inflammatory mediators
Toll-like receptors (TLRs) are known to mediate
immune responses and induce inflammatory cascades.
Fig. 1 Maternal LPS induced inflammatory response in prenatal/neonatal brains and postnatal amygdala of challenged offspring. Maternal
immune activation induces elevated circulating cytokines in the prenatal/neonatal and postnatal CNS (b, c). a Schematic representation of
experimental setup. b, c Gene expression was normalized against β-actin via ΔCt. Results are mean normalized to expression ± SEM (n = 4/treatment
group/time point). Significant difference denoted as *p < 0.05, **p < 0.01, and ***p < 0.001 in post hoc multiple comparisons performed using Tukey’s
test following one-way ANOVA
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TLR-4 is thought to mediate bacterial responses in such
that LPS is a ligand of this receptor. TLR-2 is also in-
volved in LPS-induced TLR-4 signaling and thus inflam-
mation [21]. Therefore, we investigated the effect of
LPS-induced MIA on TLR expression across stages of
amygdalar development (Fig. 2a, c). One-way ANOVA
for the main factor age showed a significant effect
for TLR-2 (F(4, 15) = 13.24, p < 0.0001) and TLR-4
(F(4, 15) = 18.3, p < 0.0001) in the prenatal/neonatal
development stages. Likewise, a significant age effect
was observed postnatally for TLR-2 (F(3, 12) = 6.45,
p = 0.0075) and TLR-4 (F(3, 12) = 3.354, p = 0.05). In post
hoc analyses, TLR-2 was significantly increased at E16
relative to saline-treated controls (***p = 0.0002) and to
LPS-treated offspring at E12 (***p = 0.0002), E18
(*p = 0.013), and P0 (***p = 0.0004). In the postnatal
amygdala, TLR-2 expression was significantly in-
creased at P40 in comparisons to saline-treated controls
(**p = 0.007) and to P14 (*p = 0.0232). TLR-4 mRNA
expression was significantly increased at E18 in com-
parison to saline treatment (****p < 0.0001) as well as to
E12 (****p < 0.0001), E16 (***p = 0.0008), and P0
(**p = 0.0022), the prenatal/neonatal stages. In the postna-
tal amygdala, TLR-4 expression was increased at P40 in
comparison to saline-treated controls and was unaffected
over other postnatal ages examined (*p = 0.050). One-way
ANOVA for the main factor age showed a significant ef-
fect for COX-2 (F(4, 15) = 3.263, p = 0.0464) and CD36
(F(4, 15) = 4.257, p = 0.0203) but did not record significant
differences for iNOS (F(4, 15) = 0.279, p = 0.8862) or CCL2
(F(4, 15) = 1.403, p = 0.2872). Likewise, a significant age ef-
fect was observed postnatally for COX-2 (F(3, 11) = 12.74,
p = 0.0007), iNOS (F(3, 11) = 3.676, p = 0.0470), and CCL2
(F(3, 12) = 5.909, p = 0.0103), but no significant differences
were noted for CD36 expression (F(3, 12) = 1.277,
p = 0.3265). In post hoc analyses, mRNA expression of
the prostaglandin-synthetizing enzyme cyclooxygenase
COX-2 was significantly increased at P40 in comparison
to saline-treated controls (Fig. 2b, d **p = 0.0012) and to
offspring treated with LPS at P7 (***p = 0.0009) and P14
(*p = 0.0281). CD36, a scavenger receptor expressed by ac-
tivated microglia/macrophages in the CNS, is implicated
in inflammatory responses [37]. CD36 mRNA expression
was significantly increased at E16 in comparison to saline-
treated controls (*p = 0.024) and higher at E16 versus P0
(*p = 0.035) but remained unaffected in the postnatal
amygdala (Fig. 2b, d). Chemokine (c-c motif ) ligand 2
(CCL2) was increased but did not reach significance in the
prenatal/neonatal ages studied (Fig. 2b, d). Post hoc ana-
lyses showed that CCL2 expression was significantly
Fig. 2 MIA-induced an inflammatory milieu in prenatal/neonatal brain (a, b) and postnatal amygdala (c, d) in offspring. Expression of inflammatory
markers and toll-like receptors (TLRs) in prenatal/neonatal brains and postnatal amygdala (a–d). TLR-4 and TLR-2 mRNA expression profiles were
elevated in the developing brain and remained significantly higher up to 40 days post insult. Gene expression was normalized against β-actin via ΔCt.
Results are mean normalized to expression ± SEM (n = 4/treatment group/time point). Significant difference denoted as *p < 0.05, **p < 0.01, and
***p < 0.001 in post hoc multiple comparisons performed using Tukey’s test following one-way ANOVA
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elevated at P40 in comparison to P14 (Fig. 2d,
**p = 0.006). The inducible form of nitric oxide (NO) syn-
thase, iNOS, was significantly upregulated in the postnatal
amygdala at P40 in comparison to saline-treated controls
(Fig. 2d *p = 0.042). Together with the enhanced mRNA
levels observed for COX-2, this elevation in iNOS mRNA
expression in MIA offspring may indicate a heightened in-
flammatory response in the postnatal amygdala (Fig. 2b, d).
Astrocyte and microglial environment is altered in the
developing amygdala after MIA
We next sought to determine if there were morpho-
logical alterations in microglia and astrocytes over the
same time course after MIA induction in the prenatal
brain (E12-P0) (Fig. 4) and postnatal amygdala (P7-P40)
(Figs. 3 and 4). Morphological analysis of Iba-1 immuno-
reactivity (ir) revealed that microglia had larger cell
bodies and thicker shortened processes consistent with a
de-ramified morphological profile in LPS groups. During
neurodevelopment, microglia have an amoeboid morph-
ology consistent with their phagocytic processes and
synaptic pruning; however, after MIA insult, these cells
exhibit an amoeboid phenotype with an activated status.
This was evident in the postnatal ages, as semi-
quantitative analysis showed that the predominant
microglial phenotype was amoeboid with an “activated”
phenotype in offspring from MIA dams. At P7, there
was a significant reduction in ramified-like “resting”
microglia (***p < 0.001), whereas microglial cells were
predominantly amoeboid after MIA (*p < 0.05). This
trend was also significantly different at P40 and more ro-
bust (Fig. 4b, f; *p < 0.05, ***p < 0.001). GFAP-ir, a marker
for astrocytes that is upregulated in inflammation and
cell damage, showed moderate astrogliosis in the amyg-
dalar region with bushy-like morphology and overlap-
ping processes in MIA offspring in comparison to
saline-treated controls (Fig. 4). In addition, GFAP-ir was
more intense in the amygdalar regions with increasing
Fig. 3 MIA induced changes in microglial morphology in the developing amygdala. Iba-1 immunoreactivity (ir) at a E12, b E16, c E18, and d P1.
GFAP expression was first present at P0 with no GFAP expression preceding this time point (e). Iba-1 positively labeled microglia exhibited
ramified and amoeboid morphologies from E12 to P0. In LPS-treated groups, microglial morphology was predominantly amoeboid with GFAP
immunoreactivity being dense along the external capsule of the amygdala. Astrocytes were hypertrophic in the LPS-treated group at P1. Scale
bar = 200 μm and inset images scale bar = 50 μm
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Fig. 4 (See legend on next page.)
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age and treatment. Labeled astrocytes indicative of astro-
gliosis were prominent along the external capsule and
also in the amygdalar region in MIA offspring, in par-
ticular at P14 (Fig. 4j). Semi-quantitative scoring of
GFAP-ir revealed the highest GFAP staining at P14 in
MIA offspring in comparison to controls (Fig. 4j).
MIA induced cytoarchitectural changes in the central
nucleus at P14
After examining the cytokine profiles in the CNS after
MIA, next we wanted to investigate the cytoarchitecture
of the postnatal amygdala (Fig. 5). It is known that in-
creased cytokine expression may have negative effects
on brain structure [28]. Here, we investigated the cyto-
architecture of the postnatal amygdala after E12 mater-
nal injection at P7, P14, and P40 in both treatment
groups with the aid of Nissl stain and classification of
cell types according to [9] (Fig. 5). Volumetric analysis
revealed that the central nucleus (Ce) was significantly
smaller at P14 after maternal LPS treatment (*p < 0.05).
Moreover, total cell counts using Nissl stain showed a
significantly lower number of the total neuron popula-
tion (**p < 0.01).
Discussion
Inflammation during pregnancy (MIA) can affect several
aspects of neurodevelopment, with disturbances that
may initiate a series of events eventually interrupting
neuronal and glial functions. MIA can induce a
“cytokine storm” in the fetal brain, which has been
shown to have negative effects on brain structure, both
biochemically and structurally. Studies inducing MIA via
LPS challenge have shown that this results in increased
microglial activation with alterations in morphology
from “resting” ramified to an “activated” amoeboid cell
type [5]. These changes may lead to downstream effects
on the cytoarchitecture of the amygdala as seen at P14, a
period known to be important for brain maturation [11].
The present in vivo study demonstrates that an acute
maternal LPS injection at E12 upregulates pro-
inflammatory cytokines and toll-like receptors in the
fetal CNS that subsequently increases glial cell im-
munoreactivity, possibly leading to a developmental
delay and/or cell loss in the postnatal amygdala.
TLRs are expressed on most immune-cell types, in
particular on microglia, which increase TLR expression
in response to inflammatory stimuli. TLR-4 is a known
receptor for LPS, and here, after MIA induction, TLR-4
was upregulated in fetal CNS tissue and remained up-
regulated in late postnatal ages suggestive of glial activa-
tion. Moreover, TLR-2 that is also known to be elevated
after inflammation was upregulated at prenatal/neonatal
and postnatal developmental ages. In addition, COX-2,
iNOS, and CCL2 were also significantly upregulated at
P40 which may further suggest prolonged glial
“activation” state. Taken together, an acute bacterial
challenge during a critical window of amygdalar devel-
opment maybe sufficient to induce inflammatory media-
tors and TLRs in the developing CNS that may persist
and affect the later development of the amygdala. How-
ever, it should be taken into consideration that other
CNS cells such as astrocytes and/or infiltrating immune
cells (monocytes, macrophages, etc.) can also produce
pro-inflammatory cytokines. During development, the
BBB is not fully formed, and infiltration from the
periphery is highly likely. While our study examined
gene expression in whole tissue lysates, isolation of
microglial cells using other technologies such as flow
cytometry might help characterizing immune cells
involved in MIA effects in future studies.
Our data suggests a particular effect at P14 on the
central nucleus (Ce) of the amygdala that had lower
neuronal numbers and corresponding volume reduction
compared to saline-treated controls. Astrogliosis, which
is an indicator of cell damage and inflammation, was
most evident in the amygdala at the same developmental
(See figure on previous page.)
Fig. 4 Increased microgliosis and astrogliosis in the postnatal amygdala after MIA. Iba-1 immunoreactivity in the saline and LPS-treated
animals also displayed distinct differences revealing clear changes in cell morphology. At higher magnification (insets of panels a, c, and
e), Iba-1-positive cells display ramified morphologies in saline-treated animals, whereas in LPS animals, they are more widely distributed
and exhibit amoeboid morphology (large cell body with thick stunted processes). Representative images (b) of Iba-1 positive microglia
that were quantified; morphologies of microglia: top panel shows a ramified microglia with long processes; lower panel shows microglia
with thick cell body, stunted processes and amoeboid morphology (b). Counts of Iba-1-positive microglia showed higher percentage of
amoeboid-like microglia at P7 and P40 in LPS-treated groups in comparison to saline-treated controls with no significant differences seen
at P14 (b, d and f). GFAP immunoreactivity was sparse in saline animals especially at earlier postnatal ages; however, it increased
considerably in the LPS-treated animals (g, h and i). Astrocyte territories overlap and exhibit cellular hypertrophy indicative of astrogliosis
at P14 (h, bottom inset) and P40 (i, bottom inset). Semi-quantitative scoring of GFAP staining intensities showed that the amygdala had
higher GFAP score at P14 in the LPS-treated groups (j). Across the ages examined, LPS-treated groups had relatively higher GFAP staining
intensities in comparison to saline control animals (j). Density of GFAP-positive cells and variation in the staining intensity (somata and
cellular processes) were included into scoring in a blinded manner as − = none (0% stained), + = very few cells (< 10% of area stained),
++ = few cells (10–25% of area stained), +++ = moderate number of cells (25–50% of area stained), and ++++ = numerous cells (> 50%
stained) (j). Scale bar = 200 μm with inset images scale bar = 50 μm. Significant difference denoted as *p < 0.05, **p < 0.01, and
***p < 0.001
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stage. The reduction in Ce volume and cell numbers in
the LPS group at P14 may indicate a developmental
delay at this time point, considering that amygdalar
development and growth continues postnatally [14],
because both the volume and cell numbers in the Ce
reached adult levels as in saline-treated offspring at P40.
Studies in rodents have shown that postnatal day 14
(P14) is a crucial period for brain maturation [36] and
synaptic pruning during this postnatal development is
known to play a vital role [31]. Synaptic pruning is par-
ticularly efficient at P14 in mice, and alterations to the
microglial functions induced by an inflammatory event
during this time or earlier may contribute to synaptic
abnormalities seen in some neurodevelopmental disor-
ders [42]. Adolescence is an important time of neurobe-
havioral maturation during which limbic structures such
as the hippocampus, amygdala, and prefrontal cortex
undergo maturation [8, 23]. It has been shown that
alteration to the microglial environment during early life
impairs synaptic elimination and negatively impacts on
functional behaviors [42]. After maternal LPS, fetal brain
IL-1β mRNA gene expression levels were significantly
elevated as soon as 4 h postinjection. The elevated pro-
inflammatory milieu early in development may “activate”
glial cells such that in later postnatal stages, they display
activated phenotypes as indicated by increased CCL2,
COX-2, and iNOS with TLR-2 and TLR-4 expression
gene expression and also increased Iba-1 and GFAP im-
munoreactivity and morphological changes. This is in
agreement with studies showing that prenatal exposure
to LPS induces elevated IL-1β expression and is
associated with postnatal cell death and gliosis [33].
Interestingly, CD36-TLR-4 signaling is implicated in
microglial inflammatory response that promotes neuro-
toxicity [37]. Our data showed that CD36 is elevated at
prenatal stages, which coincides with increased ex-
pression of TLR-4. This elevated CD36/TLR-4 expres-
sion prenatally may enhance the inflammatory profile
and thus microglial priming in the developing brains
after MIA. The transient upregulation of the anti-
inflammatory cytokine IL-10 at E16 might have con-
tributed to the temporary decline in TLRs and some
pro-inflammatory mediators in neonatal MIA offspring
and at early postnatal stages, but postnatal IL-10 levels
remained unaffected. While analyses of further anti-
inflammatory markers may allow a more comprehensive
picture of MIA-induced signaling, the current results
with upregulation of IL-1β at P7 and the pro-
inflammatory molecular profile found at P40 support the
notion that a single prenatal LPS injection can cause
long-term alterations in the forebrain including up-
regulation of TLRs, potentially permanently altering the
brain’s responsivity to infectious agents and inflamma-
tion. Elevated expression of inflammatory molecules
may combine together to have a contributing negative
effect on neurons in the postnatal amygdala, e.g., by
impairing neurogenesis, inhibiting migration and differ-
entiation, and/or inducing cell loss. However, the precise
mechanisms by which toxin-induced MIA induces fetal
brain inflammation and function remain elusive. It has
been demonstrated that it is not the toxin itself that
directly induces the effects but the soluble mediators
(cytokines, chemokines, reactive species) produced via
downstream signaling cascades [2]. Therefore, other glial
cells and infiltrating macrophages and/or monocytes
should not be ignored. CCL2 is expressed by other mye-
loid cells, such as monocytes, and acts as a chemo-
attractant; in particular, it is involved in recruiting cells
to sites of injury. Increased expression of CCL2, as seen
in our data, may induce recruitment of other myeloid
cell populations to the CNS in response to neuroinflam-
mation. Alternatively, activated astrocytes and microglial
cells may release CCL2 after MIA insult. The involve-
ment and mechanisms of recruitment of different
inflammatory cells to the developing CNS should be
explored in future studies. Furthermore, MIA may
influence immune mediators at the protein level through
various mechanisms, e.g., miRNAs can alter the expres-
sion of TAB3 downstream of IL-1β signaling after MIA
induction [18] or posttranslational modifications may
take place.
In mice, a disturbance in cytokine signaling via recep-
tor blockade or genetic deletion can produce alterations
in ASD-like phenotypes including memory deficits and
social withdrawal behaviors [3]. Furthermore, prenatal
MIA on E9-E12 enhances anxiety- and depressive-like
behavior in adult offspring [10, 24]. The central nucleus
is the major output station of amygdalar projections,
and as our data shows, the Ce structure is compromised
after MIA, which could have negative effects for neuro-
behavioral outcomes. For example, MIA-induced
changes in the Ce could alter visceral and motor
(See figure on previous page.)
Fig. 5 MIA induced cytoarchitectural changes in the postnatal amygdala. Nissl staining was carried out to examine the structural alterations in
the postnatal amygdala after MIA (a). In addition, stereological analyses were carried out to measure volume differences and cell counts in the
developing amygdala in LPS and saline-treated control pups (b-e). Analyses revealed that the amygdala at P14 is most vulnerable to neuron and
volume loss, in particular the central nuclei (b-e). A decrease in volume and also cell number was observed in the Ce at P14 (c, e). However, P7
and P40 remained unaffected with respect to LPS or saline treatment (b-e). Comparisons were carried out between each treatment with respect
to treatment using the Student t test. Significant difference denoted as *p < 0.05, **p < 0.01, and ***p < 0.001
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responses to anxiogenic and emotionally arousing stim-
uli. Because the Ce is a major regulator of the HPA axis,
alterations in the cell types and function of the Ce may
also affect inflammation by altering glucocorticoid hor-
mone function [20]. Thus, despite comparable neuronal
cell numbers between MIA and saline groups at P40, the
function of the Ce may be permanently altered after
MIA exposure, because specific subsets of peptidergic
Ce projection neurons innervating certain hypothalamic
and brainstem regions may be affected. While our study
examined the cytoarchitectural effects of MIA challenge
over development, further studies using our model may
be beneficial for correlating the structural changes in the
amygdala with behavioral outcomes of this insult, e.g.,
ASD-like phenotypes.
Conclusion
In conclusion, there is a complex interplay between the
immune and neural signaling in the developing brain,
and when an insult or disturbance such as MIA occurs,
this may negatively affect the cytoarchitecture and func-
tion of the amygdala. Our model of maternal inflamma-
tion induced an elevated cytokine and TLR response in
the fetal brain, which is associated with moderate
astrogliosis, activated microglia, and cytoarchitectural
changes in the postnatal amygdala. Our data suggests
that the developing amygdala may be particularly sensi-
tive to maternal stimuli that may influence genetically
determined developmental processes.
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